AbCellera Biologics Inc. (ABCL) — Total Assets
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $1.36B | -0.3% |
| 2024 | $1.36B | -8.6% |
| 2023 | $1.49B | -3.4% |
| 2022 | $1.54B | +16.9% |
| 2021 | $1.32B | +31.1% |
| 2020 | $1.01B | — |
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $1.36B | -0.3% |
| 2024 | $1.36B | -8.6% |
| 2023 | $1.49B | -3.4% |
| 2022 | $1.54B | +16.9% |
| 2021 | $1.32B | +31.1% |
| 2020 | $1.01B | — |